SLNO Soleno Therapeutics, Inc.
Healthcare$53.01+0.00%ClosedMarket Cap: $2.76B
As of 2026-05-25
Insider Statistics (Q2 2026)
Acquisitions
0
Dispositions
71
Buy/Sell Ratio
0.00
Net Shares
-2,478,876
Shares Acquired
0
Shares Disposed
2,478,876
Total Bought ($)
$0.00
Total Sold ($)
$0.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Mon May 18 | Yen Kristen | officer: SEE REMARKS | Sell | 55,392 | $5.25 | 0 |
| Mon May 18 | Yen Kristen | officer: SEE REMARKS | Sell | 37,639 | $0.00 | 0 |
| Mon May 18 | Yen Kristen | officer: SEE REMARKS | Sell | 18,800 | $33.60 | 0 |
| Mon May 18 | Yen Kristen | officer: SEE REMARKS | Sell | 16,000 | $36.70 | 0 |
| Mon May 18 | Yen Kristen | officer: SEE REMARKS | Sell | 11,667 | $2.41 | 0 |
| Mon May 18 | Yen Kristen | officer: SEE REMARKS | Sell | 4,999 | $24.00 | 0 |
| Mon May 18 | Yen Kristen | officer: SEE REMARKS | Sell | 4,000 | $25.05 | 0 |
| Mon May 18 | Yen Kristen | officer: SEE REMARKS | Sell | 2,445 | $5.10 | 0 |
| Mon May 18 | Yen Kristen | officer: SEE REMARKS | Sell | 1,741 | $44.25 | 0 |
| Mon May 18 | Yen Kristen | officer: SEE REMARKS | Sell | 666 | $51.15 | 0 |
| Tue Mar 31 | Manning Meredith | officer: Chief Commercial Officer | Sell | 4,864 | $30.04 | 67,165 |
| Tue Mar 31 | Manning Meredith | officer: Chief Commercial Officer | Sell | 2,100 | $31.04 | 65,065 |
| Tue Mar 31 | Manning Meredith | officer: Chief Commercial Officer | Sell | 558 | $31.72 | 64,507 |
| Tue Mar 31 | Huang Michael F. | officer: Sr. VP of Clinical Development | Sell | 4,256 | $30.04 | 42,149 |
| Tue Mar 31 | Huang Michael F. | officer: Sr. VP of Clinical Development | Sell | 1,838 | $31.04 | 40,311 |